By Liz MoyerInvesting.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer...
Shares of Moderna (NASDAQ:MRNA) are up 5% in premarket trading Wednesday after the company reported better-than-expected Q1 revenue.The pharmaceutical company reported a Q1...
Pre-Open Stock Movers:Livent Corporation (NYSE:LTHM) 26% HIGHER; reported Q1 EPS of $0.28, $0.15 better than the analyst estimate of $0.13. Revenue for the quarter came in at...
Moderna reported Q1 results May 4, beating earnings expectations by more than 60%Shares are 72% below the 12-month high closing price hit Aug. 9Consensus rating is bullish, with...
Stocks on Wall Street plunged on Friday, with the tech-heavy NASDAQ Composite suffering its worst month since 2008, as technology shares sank following disappointing earnings and...
Investors will be bracing for another volatile week in the stock market this week on signs that ongoing bearish sentiment has more room to run, especially when an adverse...
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. The company has 44 development programs, which includes 26 in clinical trials across seven modalities comprising prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic intracellular therapeutics, and inhaled pulmonary therapeutics. The company has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Buy | Sell | Neutral |
| Technical Indicators | Strong Sell | Buy | Strong Buy | Sell | Sell |
| Summary | Neutral | Buy | Strong Buy | Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 37.50 | 39.19 | 36.89 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.14 | 0.145 | 0.138 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 2.29 | 2.31 | 2.21 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 8.25 | 8.335 | 8.22 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 1.14 | 1.155 | 1.085 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.16 | 0.16 | 0.155 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 14.60 | 14.63 | 14.28 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 10.46 | 10.49 | 10.28 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 2.17 | 2.21 | 2.17 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 1.60 | 1.62 | 1.57 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.195 | 0.195 | 0.19 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 6.82 | 7.13 | 6.74 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 6.13 | 6.14 | 6.05 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 4.58 | 4.68 | 4.55 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 3.99 | 4.01 | 3.95 | 0.000 | 0.00% | 0.00 | Sydney |